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Extensive studies were performed to decipher the mechanisms regulating feeding due
to the worldwide obesity pandemy and its complications. The data obtained might be
adapted to another disorder related to alteration of food intake, the restrictive anorexia
nervosa. This multifactorial disease with a complex and unknown etiology is considered
as an awful eating disorder since the chronic refusal to eat leads to severe, and
sometimes, irreversible complications for the whole organism, until death. There is an
urgent need to better understand the different aspects of the disease to develop novel
approaches complementary to the usual psychological therapies. For this purpose, the
use of pertinent animal models becomes a necessity. We present here the various
rodent models described in the literature that might be used to dissect central and
peripheral mechanisms involved in the adaptation to deficient energy supplies and/or
the maintenance of physiological alterations on the long term. Data obtained from the
spontaneous or engineered genetic models permit to better apprehend the implication
of one signaling system (hormone, neuropeptide, neurotransmitter) in the development
of several symptoms observed in anorexia nervosa. As example, mutations in the
ghrelin, serotonin, dopamine pathways lead to alterations that mimic the phenotype, but
compensatory mechanisms often occur rendering necessary the use of more selective
gene strategies. Until now, environmental animal models based on one or several inducing
factors like diet restriction, stress, or physical activity mimicked more extensively central
and peripheral alterations decribed in anorexia nervosa. They bring significant data on
feeding behavior, energy expenditure, and central circuit alterations. Animal models are
described and criticized on the basis of the criteria of validity for anorexia nervosa.
Keywords: genetic models, environmental models, anorexia nervosa, acute stress, social stress, food restriction,
activity/hyperactivity
Introduction
Eating disorders represent a large field of investigation in industrialized societies where food
intake behaviors and quality of food become indisputable and incoherent. Research projects are
currently focused on obesity, a dramatic consequence of overconsumption of fat and carbohy-
drates. However, populations of these societies also suffer of other dramatic but underinvestigated
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eating disorders. These eating disorders are presently defined
according to the American Manual of Psychiatry DSM-5 (1) and
divided into three main subtypes of eating disorders: anorexia
nervosa (AN), bulimia nervosa (BN), and binge eating disor-
der (BED). The main characteristics of these three subtypes
are summarized in Table 1. As usually mentioned by psy-
chiatrists, the subtype determination at the time of diagnosis
should be considered carefully since the majority of women
with AN crossed over between the other subtypes [BED or
BN; (2)].
Anorexia is said to be restrictive if during the past 3months
the person has not engaged in recurrent bulimic crises or purging
behavior (i.e., self-induced vomiting or abuse of laxatives, diuret-
ics, or enemas). One might consider this restrictive AN (AN-R)
subtype as an awful eating disorder as the chronic refusal to eat
leads to severe and sometimes irreversible complications for the
whole organism, until death. AN-R is considered as a multifacto-
rial disease with a complex etiology. The dramatic physiological
and psychological consequences on health generated by the low
food intake might lead to central and/or peripheral reprograming
that permits the organism to endure in a first step, this reduced
energy supply. A better understanding of the different facets of
this disease becomes an urgent necessity to find novel therapeutic
approaches complementary to the classic psychological therapies.
The objectives of this review are first to present briefly the
main pathophysiological alterations observed in AN-R patients,
then to introduce the different animal models that are currently
used or could be used to better apprehend the physiological,
metabolic, and neurobiological dysfunctions associated with AN-
R, and finally to discuss the potential contribution of thesemodels
for understanding the pathology.
Physiological Alterations in Restrictive
Anorexia Nervosa: From Neurobiology to
Genetic Polymorphisms
The two faces of anorexia, physiological and psychological, which
were first used to describe the disease, then were neglected by
the psychiatrists and psychologists for years are now more and
more widely accepted by numerous clinicians and practicians to
interfere.
Physiopathological Alterations
The recent DSM-5 (2013) suggests diagnosing AN-R by three
major criteria. The first criterion is a severe and persistent restric-
tion of energy intake leading to significantly low body weight in
context of what is minimally expected for age, sex, developmental
trajectory, and physical health. The gradual loss of weight can
reach more than 50% of the initial body weight. The second crite-
rion is the intense fear of gaining weight or of becoming fat. The
third criterion is a disturbance in the way AN patients experience
their body weight or shape (dysmorphophobia), associated with
persistent lack of recognition of the seriousness of the current
low body weight. Another important criterion, amenorrhea or the
absence of at least three menstrual cycles, was removed in the
DSM-5. This criterion was deleted since it cannot be applied to
patients of different age and gender.Moreover, some data describe
individuals who exhibit all other symptoms and signs of AN, but
still report some menstrual activity (5, 6).
Anorexia nervosa has one of the highest mortality rates of all
psychiatric diseases (7, 8). In a 21-year follow-up study, Löwe
et al. (9) showed that 16% of AN patients deceased due to con-
sequences of the illness. Among them, about 50% died because of
somatic complications and the other 50% committed suicide. In
fact, the course of AN is extremely variable, with approximately
50–60% of individuals with AN that recover, 20–30% that partially
recover, and 10–20% that remain chronically ill (9, 10). Among
the different clinical studies conducted on AN patients, low ionic
plasma concentrations, symptomatic hypoglycemia, and anemia
are often associated with lymphopenia that can generate oppor-
tunistic infections or hepatic cytolysis in some cases. However,
contradictory results were published concerning essential amino
acid levels in plasma of AN patients and healthy controls (11–13).
Modifications in essential metabolites might be related to the gen-
eralized amyotrophy often described in AN patients. Moreover,
increase in the metabolic hormone levels (like ghrelin or cortisol)
is often observed, and the endocrine function of adipose tissue is
modified resulting in increased circulating levels of adiponectin
and decreased concentrations of leptin (14, 15). Usually, AN-R
patients also showed a nutritionally acquired hepatic resistance
to GH with decreased production of IGF-1 and increased GH
levels. Such increase is due to (i) a reduction of IGF-1 feedback
on pituitary and hypothalamus GH secretion and (ii) high levels
of ghrelin, a GH secretagogue (16). Additionally, osteoporosis,
TABLE 1 |Main characteristics of the mean eating disorders: anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED).
AN BN BED
BMI <17.5 kg/m2 >17.5 kg/m2; <25 kg/m2 >17.5 kg/m2
Lifetime prevalence 1.9–2.6% (3) 0.5–1.5% (4) 2–3.5% (4)
DSM-5 Distorted body image, excessive dieting Recurrent episodes of binge eating followed by
inappropriate purging behaviors (self-induced
vomiting)
Recurrent episodes of eating significantly more
food in a short period of time than most
people would eat under similar circumstances,
feelings of lack of control
Personality traits Anxiety, fear to gain weight, avoidance,
perfectionist, poor self-esteem,
compulsivity dysmorphophobia
Anxiety, avoidance, poor interoceptive awareness,
ineffectiveness, self-directedness, stress
reactivity, perfectionism
Anxiety, poor self esteem, harm avoidance,
impulsivity
Comorbidities Anxiety, depression, TOC, addiction,
phobia
Anxiety, depression, TOC, addiction, phobia
(obesity)
Anxiety, depression, TOC, addiction, phobia,
obesity
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another main complication of AN affecting 20–50% of cases,
has been observed and is often irreversible (17, 18). Behavioral
changes like physical (or intellectual) hyperactivity observed in
31–80%of the casesmight also be associatedwithAN (19). Finally,
disordered fluid intake is currently associated with AN-R, 54% of
patients drinking excessively, and 28% drinking restrictively (20).
This leads to relatively frequent renal complications (21).
Neurobiological Alterations
Anorexia nervosa is often associated with psychiatric comorbidi-
ties like depression, anxiety, obsessive–compulsive or personal-
ity disorders, and drug abuse (22). It becomes more and more
accepted that AN-R resembles an addictive behavior disorder
linked to food deprivation, weight loss, or physical activity. In
fact, neuroimaging studies have first pointed out morphological
changes affecting gray and white matters (23). The systematic
review of Phillipou et al. (24) summarizes a number of brain
differences, which are reported in AN patients. The neural profile
of AN corresponds to a predominant imbalance between the
reward (meso-cortico-limbic system) and inhibition (prefrontal
cortex) systems of the brain. Recent data of Kullmann et al. (25)
suggest that AN patients showed a reduced connectivity in the
brain areas involved in the cognitive control and an increased
connectivity in regions important for salience processing. The
demonstrated altered integrity of the inferior frontal cortex might
contribute to the physical hyperactivity developed by AN patients
due to its role in the general behavioral inhibition like motor
response. Furthermore, dysfunction of the central monoaminer-
gic systems has been related. The review of Bari and Robbins
(26) describes the implication of these systems as pathological
neural substrates of diseases. They underline that prefrontal nora-
drenergic neurotransmission is involved in the inhibition of an
already initiated response whereas dopaminergic system appears
to modulate motor readiness for both inhibition/activation and
reward, respectively at the level of the dorsal and ventral striatum.
Dopamine has been associatedwith the expression of an appetitive
reward system (27), and probably works in mutual opponency
with a system that signals the prediction of punishment instead
of reward. Serotonin neuromodulation might contribute to the
more affective part of the inhibition behavior and/or the wanting
behavior. Serotonin has a critical role in the adaptation of animals
to aversive events, in the inhibition of appetite, and in anxious
and obsessive behaviors, as well as in depression. Furthermore,
harm avoidance is a temperament trait highly observed in AN
patients (28), that reflects inhibition and anxiety and involves
both dopamine and serotonin (5-HT) neurotransmission (29).
AN patients show decreased dopaminergic metabolite levels in
the cerebro-spinal fluid as well as increased dopaminergic D2/D3
receptor density (30, 31). Similarly, levels of serotonin markers
like blood serotonin contents, plasma tryptophan are lower in AN
patients compared to non-eating disordered subjects (32). Brain
imaging studies using serotonin-specific radioligands have consis-
tently shown 5-HT1A receptor binding is increased in cortical and
limbic structures in ill and recoveredANpatients (33, 34), whereas
5-HT2A receptor binding remains normal in ill patients (33). 5-
HT transporter activity is also increased in recovery AN patients
(35). The basal hyperfunctioning of the serotonergic pathway
described in these various studies may be related not only to
alteration in the reward process of food intake but also to anxiety,
behavioral inhibition, and body image distortions (29, 36, 37).
Finally, one might also consider the involvement of the endo-
cannabinoid neurotransmission in the neurobiological changes
observed inANpatients. As reviewed byMonteleone andMaj (38)
in a positron emission tomography study, AN patients showed a
dysregulated endocannabinoid tone with enhanced plasma anan-
damide (AEA) levels and an increased number of cannabinoid
type 1 receptors (CB1) in the insula and inferior frontal and tem-
poral cortex of underweight AN patients. These data underline
or suggest that altered food intake in AN patients may be a con-
sequence of aberrant reward processing combined with an exag-
gerated cognitive control [see review in Ref. (39)]. Consequently,
the current psychopharmacologic strategy in the treatment of AN
uses typical and atypical antipsychotics, tetrahydrocannabinol,
anticonvulsants, antidepressants, which modulate the synaptic
signals of these neuromediators, but which have been illusive for
decades [see Ref. (40)]. Thus, dissecting themechanisms of action
of the different neuropeptides/neurotransmitters involved in the
regulation of food intake, as well as in the motivational aspects of
feeding, becomes a necessity to open new perspectives for an effi-
cient therapy of this disease complementary to the psychological
approaches.
Genetics
As clearly summarized by Scherag et al. (41), formal genetic
studies suggested a substantial genetic influence in eating disor-
ders and particularly in AN. The possible involvement of genetic
components was strengthened by several twin and family studies
concluding that AN presents genetic etiological components for
33–84% of the patients (42–45). Beside this, genome-wide link-
age screens have been performed in order to identify unknown
genes involved in AN. In the following paragraphs, presented data
without reference to publication where cited in Scherag et al. (41).
Investigation on the genes directly involved in the regulation
of feeding and energy expenditure was performed. The leptiner-
gic–melanocortinergic system includes several key factors of the
regulation of food intake and body weight. Surprisingly, despite
the anorexigenic role of the leptin hormone, critically involved in
the regulation of energy balance and adaptation of organism to
semi-starvation, mutation analysis of the leptin gene and of the
leptin receptor gene did not show any association with AN (46,
47). Agouti related peptide (AgRP), an orexigenic peptide, acts
downstream of leptin through inhibition of central melanocortin
receptors (MC receptors). Several studies concluded that the
Ala67Thr AgRP polymorphism is significantly associated with
AN. However, the involvement of this polymorphism in AN
patients remains to be determined. This mutation would cause
a lower inhibition the MC4R, a decrease in food intake, and
would increase the risk of developing anorexia (48, 49). Brain-
derived neutrophic factor (BDNF) is indirectly involved in the
negative control of food intake. Low plasma levels of BDNF were
determined in acute patients with AN. Several studies found that
variants of BDNF and BDNF receptors (TrkB) are associated with
AN. Moreover, AN patients often display high plasma levels of
adiponectin, an adipocyte hormone known to play a role in the
regulation of food intake and energy expenditure. Recently, a Ger-
man study showed that several single nucleotide polymorphisms
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within the adiponectin (AdipoQ) locus were associated with
adiponectin serum levels or eating behavior (50), but there is no
convincing published study on the linkage between adiponectin
gene polymorphism and AN.
Among the neurotransmitters suspected, genes involved in the
serotonergic and dopaminergic systems have been pointed out.
An overexpression of serotonin was suggested in AN. An asso-
ciation was shown with AN for serotonin transporter, serotonin
receptors, and tryptophan hydroxylase 2 expressions. Moreover,
positive but non-significant associations were also observed for
dopamineD2 andD4 receptors and catechol-O-methyltransferase
genes. The norepinephrine system was also investigated as low
norepinephrine serum levels were always measured in recovery
AN patients. Variants of the norepinephrine transporter gene
that could lead to a lower norepinephrine reuptake have been
associated with AN.
The endocannabinoid system is particularly involved in the reg-
ulation of appetite, food intake, and energy balance. Cannabinoids
stimulate food intake through activation CB1. A study on 52 fam-
ilies showed that an allele of CB1 gene was more often transmitted
in the restricted AN group. Moreover, in the Japanese population,
Ando et al. (51) showed an association of a polymorphism of fatty
acid amide hydrolase, which role is to inhibit the activity of the
main CB1 ligand (N-arachidonoyl-ethanolamide), with AN.
As a first general comment on these data, it is to note that for
several genes there is no evidence to suggest that any of the poly-
morphisms identified has a functional consequence on the biolog-
ical activity or expression of the resulting protein. This may lead
us to ponder these data when we try to establish linkages between
polymorphisms and physiology or etiology. A second conclusion
is that most of the polymorphisms that were shown to be asso-
ciated with AN are related to the central nervous system, and
particularly factors involved in the regulation of energy balance.
Inputs of Animal Models of AN
Development of appropriate animal model of AN appears to be
something difficult given the complex etiology. Although psycho-
logical factors play a pivotal role in the development of AN, a
better understanding of the biological basis of this eating disorder
can help to improve current treatments additional to therapies
currently used by psychologists and psychiatrists. However, due
to obvious ethic reasons, all the aspects of AN remain difficult
to assess rendering necessary to develop relevant animal models.
Thus, in rodents, different genetic and environmentalmodels have
been developed with varying degrees of success.
Genetic Models
Two categories of genetic models are commonly used: models
presenting spontaneous mutations and genetically engineered
models that can be constitutive or conditional.
Spontaneous Mutations
Anx/anx mice
This model has been extensively studied and described (52).
The mutant mice anx/anx emerged spontaneously in the Jackson
Laboratories (Bar Harbor, USA) in 1976. These mice are charac-
terized by an emaciated appearance, a reduction in food intake,
and early death 3–5weeks after the birth (53). Moreover, seroton-
ergic hyperinnervation and decrease in the striatal dopamine con-
centration and its metabolites may contribute to alterations in the
locomotor and reward systems (54, 55). The anx/anx phenotype
is associated with an approximative 50% downregulation of the
gene Ndufaf1 in the hypothalamus. It encodes a protein required
for assembly of mitochondrial complex I (56). These mice exhib-
ited several deviations in the hypothalamic neurotransmitter and
neuropeptidergic systems involved in the regulation of food intake
and energy metabolism, with a down-regulation of anorexigenic
peptides POMC and CART and variations in the expression of
the orexigenic NPY and AgRP peptides in the arcuate nucleus (54,
57–59). The reduction of the leptin peak, usually observed around
postnatal day 8, could alter the arcuate neuronal development
(60). These data are associated with mitochondrial dysfunction
and neurodegeneration/neuroinflammation processes (52, 56, 61,
62). All these data suggest that this natural genetic model of
anorexia represents an excellent model of anorexia–cachexia syn-
drome characterized by an inflammatory response that might be
useful to dissect mechanisms that lead to physiological dysfunc-
tions observed in AN. Here, the main limitations of this genetic
anorexia model are: (i) the premature death of the mice before
reaching puberty and (ii) effects observed on both male and
female mice.
Lou/C rats
Lou/C rat is a rat substrain obtained from a Wistar rat selec-
tion at the Louvain University (Belgium). Lou/C rats are mainly
characterized by a long life span until 35months in male and
40months in female (63, 64). These rats present the particularity
to be resistant to diet-induced obesity and age-induced obesity
since they exhibited a spontaneous food restriction, by eating
fewer calories per day thanWistar rats in standard chow diet (63).
The decreased food intake level is associated with a lower body
weight (65, 66) itself associated with high energy expenditure and
high sympathetic tone in thewhite and brown adipose tissues (67).
Interestingly, Lou/C rats develop also an osteoporosis related to
age associated with increased bone marrow adiposity (68). Lou/C
rats mimic leptin, insulin, ghrelin, GH, and IGF-1 alterations
observed in AN patients (66, 69–71). At central level, Lou/C rats
present an upregulation of the hypothalamic AgRP, NPY, and
orexinmRNA, and a down-regulation of leptin and ghrelin recep-
tors in the arcuate and ventromedial hypothalamic nuclei (70).
Even if this rat strain presents various common alterations
observed in AN patients, it is a more suitable model of healthy
aging (64, 72).
Genetically Engineered Mice
Beside spontaneous mutation models, various genetically engi-
neered models have been developed. In humans, genomic asso-
ciation studies have shown that various gene polymorphisms
seem particularly linked to AN (see “Genetics”). In view of
these data, we have summarized results from studies on ani-
mal models with modified genes encoding molecules involved
in neuropeptidergic circuits and monoaminergic systems. For a
more complete overview, animal models based on genetic alter-
ations of peripheral factors are also presented (Table 2). It is
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noteworthy that the interest of all these models is discussed inde-
pendently of the purpose of the original studies and thus of their
intrinsic interest.
Peripheral factors: hormones involved in the regulation of
the energy metabolism
As a consequence of leptin anorexigenic function, leptin-deficient
(ob/ob) or leptin receptor-deficient (db/db) mice display a pheno-
type of hyperphagia and obesity [see reviews in Ref. (76, 102)].
Even if the plasma levels of leptin are low in AN, these genetic
models did not mimic pathology alterations. Mice overexpress-
ing the ghrelin peptide in their stomach show higher plasma
levels of bioactive (acyl) and total (acyl and non-acyl) ghrelin.
They display a slight increase in food intake but not in body
weight (79). To increase acyl-ghrelin plasma levels, it might be
necessary to also increase the expression of GOAT (ghrelin O-
acyltransferase), enzyme involved in the ghrelin acylation. Con-
tradictory results were obtained for GOAT expression levels in
stomach after 12–36 h of fasting, whereas chronic and severe food
restrictions (21 days, 70% restriction) increase GOAT expression
in rat (103).Mice overexpressingGOATdisplay higher concentra-
tions of acyl-ghrelin without any changes in body weight or food
intake (80). Thus, engineering genetic alterations of the ghrelin
system in mice did not succeed in mimicking AN alterations
despite the essential role of this hormone in the maintenance of
glucose homeostasis on food restriction condition (104–106). The
anorexigenic peptide PYY is physiologically released in response
to food intake and its plasma levels increased in patients with
AN. Mice overexpressing PYY display normal weight gain and
food intake (77). These observations could suggest that this
model should be excluded from the list of AN models, but a
recent study (78) showed that when PYY overexpression begins
in adult mice, it induces a reduced food intake after 24-h fasting.
However, these mice display no significant difference of body
weight or energy expenditure when compared to wild type mice.
The pancreatic polypeptide (PP) produced in pancreas after food
intake inhibits gastric emptying, and contributes to the important
satiety effect of cholecystokinin (CCK). Baseline PP concentra-
tions were similar between AN patients and healthy controls
(107) or higher in AN patients (108), but these concentrations
increased much more in AN patients than in controls after a
meal test (107, 108). Transgenic mice over-expressing PP dis-
play a slightly lowered body weight associated with a modest
reduction of food intake (81). CCK is a gut hormone stimu-
lated by fatty meals and inducing satiety. It is also involved in
the control of gastrointestinal motility and in anxiety behaviors.
The response of CCK to a meal test was four-fold lower in AN
patients than in healthy control group (107). Interestingly, CCK
deficient mice display a normal food intake and a normal body
weight when fed a basal diet (82, 83). Thus, once again, this
model does not mimic the main alterations observed in patients
with AN.
Neuropeptidergic systems
Modifications in the expression of neuropeptides permit to gener-
ate central alterations that might explain mechanisms giving rise
to some of the symptoms described in AN patients.
In the arcuate hypothalamic nucleus, the two populations
of orexigenic and anorexigenic neurons and their receptors,
respectively the AgRP/NPY and αMSH/CART (α-melanocyte
stimulating hormone/cocaine amphetamine related peptides)
neurons, have been the focus of numerous studies in an attempt
to better understand the finely tuned regulation of food intake.
During fasting, NPY andAgRP gene expressions are up-regulated,
and αMSH and CART gene expressions are down-regulated
in hypothalamus. Moreover, various experiments suggest that
NPY/AgRP inhibits directly the activity of αMSH neurons
through a corelease of GABA, as well as an action on MC4R-
bearing cells. Inactivation of genes encoding NPY, AgRP, or both
has little effect on energy balance (109). Mice KO forNPY present
significant changes neither in their body weight nor in their
food intake, but become hyperphagic following food deprivation
(110, 111). Surprsingly, mice KO for both Y2 and Y4 receptors
exhibited a reduction in adiposity and an increase in lean mass,
but without significant changes in food intake. Energy expen-
diture and physical activity were significantly increased in Y4-
KO and particularly in Y2-KO/Y4-KO (87). Such models might
be valuable to study the involvment of NPY and its receptors
in the modulation of body composition and energy metabolism
that are dramatically disturbed in AN. Contrary to the Y2 and
Y4 receptors, the Y1-KO and Y5-KO mice develop the late-onset
obesity with an increase in food intake and adiposity (112–114).
This implies compensatory mechanism in feeding behavior in
these KO mice and underlines the complexity of the NPY-food
intake regulation system. Selective acute deletion ofAgRP neurons
in the adult mouse inhibits feeding and can lead to starvation
not observed when the ablation is performed in neonatal mice
before AgRP neurons are mature (85). Wu et al. (115) show in
Ay/a mice no discernable effect on the anorexia phenotype caused
by AgRP neuron ablation, suggesting that excessive activation
of the melanocortin signaling is not responsible for starvation.
Compensatorymechanismsmay occur and hide the potential role
of certain peptides (116, 117). Unfortunately, in these models,
physiological data are rarely presented, their use are of interest to
better understand the dialog existing between these populations
of neurons by deciphering the involvement of their receptors
in specific conditions. These approaches can highlight the main
homeostatic pathway disturbed in AN.
The lateral hypothalamus containsMCH (melanin concentrat-
ing hormone) orexigenic neurons, described to be essential in the
control of food intake and physical activity (88). In his review,
Macneil (118) points out the various mouse models where dis-
ruption of MCH signaling results in altered energy homeostasis.
Indeed, targeted inactivation of the MCH gene in mice induces
reduced body weight and leanness due to hypophagia associated
with an increased metabolic rate, despite reduced amount of both
leptin and arcuate nucleus proopiomelanocortin mRNA (88). KO
MCH mice also display an increased running-wheel activity dur-
ing dark period (89). In the Promch/ataxin-3 mouse, 60–70% of
MCH-expressing neurons degenerate in the first few weeks of
life. Thus, at the age of 7-week, mice developed reduced body
weight due to hypophagia and increased energy expenditure, body
length, fat mass, lean mass, and leptin levels (119). Similarly,
the Mchr1 /  mice were less susceptible to diet-induced obesity,
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and the leanness was a consequence of hyperactivity and altered
metabolism. The manipulation of the MCH system remains one
of the most interesting to reproduce many of the symptoms
described in AN. The progressive degeneration of an orexigenic
neuronal population induces a voluntary food restriction that
impacts the overall physiology of the animal.
The lateral hypothalamic area also comprises another popula-
tion of orexigenic neurons: the orexin/hypocretin (Hcrt) neurons
which are implicated in various functions altered in AN. Indeed,
in a neuron-ablated strategy, the orexin/ataxin-3 transgenic mice
severely reduced the formation of food anticipatory activity (FAA)
under food restriction conditions (120). Furthermore, in a recent
study, Ramanathan and Siegel (121) report gender differences in
Hcrt KO mice. Hcrt KO females had increased body weight asso-
ciated with increases in various components of the body compo-
sition, despite a decreased food and water intake not observed so
drastically in themales. This promisingmodel remains complex to
interpret in the case of AN, because of the multiple roles in which
orexin is involved.
Among the other neuropeptidergic systems involved inAN, the
cannabinoid systemmust be pointed out.Mice invalidated for CB1
in hypothalamus showed a significant weight loss associated with
greater energy expenditure despite a normocaloric food intake in
standard diet (90). The mechanisms involved in such adaptations
need to be more investigated since pharmacological manipulation
of the endocannabinoid system is currently discussed as potential
strategy for the treatment of anxiety disorders, depression, and
AN (122, 123). Similarly, the opioïd system is known to play a
role in the control of homeostatic and hedonic pathways. Thus,
mice knockout for the opioid receptors like the µ-receptor display
no significant difference in body weight, food intake, locomotor
activity, or dark respiratory quotient when fed with regular chow
diet compared to wild type mice, but they are resistant to diet-
induced obesity and display more important weight loss during
food deprivation (124–126). They also show a decrease in food
motivation as demonstrated in an operant paradigm for chow diet
or sucrose pellets, and a reduction of FAA in a daily scheduled
food access compared to wild type mice (127, 128). These models
might be of interest more specially to dissect the complex mecha-
nisms that regulate the non-homeostatic aspects of the feeding in
AN patients.
Neurotransmitters: dopamine and serotonin
As mentioned above, in AN patients, neuroimaging studies as
well as dosages in the cerebro-spinal fluid report alterations in the
serotonergic and dopaminergic systems.
Concerning the serotonergic system, pharmacological treat-
ments that increase serotonin disponibility lower consumption of
food in humans and rodents (129, 130). Themodel ofmice geneti-
callymodified for 5-HT4 receptors has been extensively studied as
a model of anorexia (131). Briefly, these mice were characterized
by a voluntary food restriction, only following restrained stress,
and by an attenuation of novelty-induced exploratory activity (92).
Conversely, the knockdown of 5-HT4 receptor in nucleus accum-
bens increases food intake only in fed mice (93). Likewise, mice
lacking 5-HT1B receptor food restricted (20%, 3 days) eat less
than the wild type mice when standard food ration is given. They
also show an increased locomotion (94). Mice lacking 5-HT1A
receptor or wild type mice chronically treated subcutaneously
with a 5-HT1A receptor agonist display a decrease of their food
intake (95). The interpretation of data obtained from manipula-
tion of the serotonergic system is rendered difficult due to the large
number of receptors and the various effects they have depending
of their location at the synaptic level and in the brain. Thus, to
better elucidate the role of serotonin in the feeding behavior, it is
preferable to use conditioned deletion or the cre-lox technology to
avoid large effects that might be more the result of compensatory
mechanisms than a true action of the neurotransmitter.
Concerning the dopaminergic system, Szczypka et al. (96) used
initially a gene-targeting strategy to inactivate specifically the
tyrosine hydroxylase (TH) gene in dopaminergic neurons, spar-
ing the production of dopamine as a precursor for adrenaline
and noradrenaline. These mice, called “dopamine deficient mice,”
became hypophagic and died from starvation at 34 days because
they showed locomotor deficiencies. Routine treatment with -
DOPA restored a food intake similar to wild typemice. Using viral
strategy (96, 132–134), the involvement of dorsal striatum and
accumbens nucleus has been demonstrated in locomotion and
motivation, respectively, underlining the importance of dopamine
to execute behaviors necessary to seek and ingest properly food. In
AN, dopamine deficiencies might contribute to alterations in the
accomplishment of these behaviors. Moreover, motivation aspects
of feeding are also under the influence of medial prefrontal cortex
and amygdala as recently demonstrated and involved D1 and D2
receptors (135, 136). These recent data emphasize the complexity
of the regulation of feeding motivation, complete brain imaging
data obtained in humans in these brain regions, and point out the
need of more targeted pharmacological treatments (137).
Other genes
Other genes are also studied in the case of AN and are poten-
tial targets involved in the maintenance and/or evolution of the
disease, like BDNF (brain-derived neurotrophic factor), CRH
(corticotropin-releasing hormone), the glutamate receptors, the
muscarinic type receptors even if they are also involved in a variety
of functions (138, 139) rendering difficult to dissect precisely
their actual role in the regulation of hunger/feeding. BDNF, a
neurotrophic factor, is also a central regulator of energy balance,
since BDNF suppresses food intake by acting on hypothalamic
neurons (97, 98). Unfortunately, to our knowledge, no studies on
hypothalamic overexpression of BDNF and feeding behavior are
described in the literature. Investigating the CRH system in the
case of AN is rendered difficult, even if the link is obvious, since
AN patients often present stress-related disorders like anxiety and
depression.Among the geneticallymodifiedmodels, theCRH-KO
mice model described by Jacobson (100), the mice fed with chow
diet present a decreased food intake associated with a lowered
body weight loss than mice fed with restricted protein diet. In the
opposite, mice who overexpress central CRH display changes in
autonomic variables, like increased body temperature and heart
rate, as well as increased food and water consumption, when
compared with wild type mice (101). Thus, as detailed along the
review, theHPA axis plays a key role in the regulation of the home-
ostatic and non-homeostatic aspects of the AN altered feeding,
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but the precise role remains to be determined in this case due to
numerous brain areas involved. Muscarinic receptors (M1 to M5)
are involved in acetylcholine signaling and in various functions
at peripheral and central level (140). The M3 receptor has been
associated with alterations that are observed in AN. Indeed, M3
KO mice are hypoactive and display a voluntary food restriction
associated with lower body weight compared to wild type mice.
These transgenic mice also present lower fat deposits associated
with reduction of plasma leptin and insulin concentrations.More-
over, M3 KO mice present an up-regulation of AgRP and down-
regulation of POMC and MCH in hypothalamus compared to
control (99). Due to the large distribution of these receptors in the
CNS, targeted strategies of gene deletion must be chosen to assess
precisely their involvement in the regulation of food intake (141).
Conclusion
The main results obtained on mouse models in which one gene
expression was modified to follow the alteration of the corre-
sponding protein levels described in ANpatients was summarized
on theTable 2. These lead us tomention thatmost of thesemodels
are more relevant for obesity or display no specific phenotype
related to AN. Interestingly, this table points out that most of the
alterations related to these genes induce phenotypes very different
of the pathologic ones. This could be linked to the fact that alter-
ations of factors in AN patients appear often to be opposite to the
physiological and behavioral alterations obtained in these genetic
models. As examples, the plasma levels of leptin and ghrelin,
respectively, low and high in AN patients, might normally lead
to an increase in food intake, which is not the case in the disease,
reflecting a physiological adaptation that is not well-perceived at
the central and/or peripheral levels.
Thus, even if these genetic models gave comprehensive infor-
mations about some mechanisms related to the processes regulat-
ing homeostatic and non-homeostatic regulation of food intake,
these models are most often used on short term protocols and
do not allow to follow the physiological and neurobiological
evolutions of the phenotype while restrictive AN is usually a
chronic disease. Furthermore, they focus on certain aspects of
the disease such as hypophagia, hyperactivity, or motivational
disturbances without taking into account a general view of the
whole body functioning. To circumvent these drawbacks, the use
of “environmental” model allows us to reconsider some of these
aspects.
Environmental Models
Various environmental animal models have been proposed to
mimic various symptoms of AN. These models are usually based
on qualitative or quantitative modifications in the pattern of
distribution of the meal, including period of quantitative food
restriction or limited time of food access as well as exposure to
chronic or acute stress.
Animal Model Based on One Inducing Factor
Dietary restriction models
Various studies have focused on adaptations induced by dietary
restriction to determine contribution of energy imbalance or
nutriment deficiency in changes observed in AN patients. Some
studies focused on life span, cancer prevalence, or metabolic
syndrome have brought data useful for understanding AN-related
alterations [see review in Ref. (142)]. Altogether, the different
feeding paradigms lead to various but complementary results.
Food restriction (FR)
Most of the studies using chronic FR used mild restriction pro-
tocols. Restricted animals were fed usually 30–40% less than
ad libitum control ones. However, it must be noted that in animal
facilities, rodents are usually overfeed of about 30% compared to
their physiological needs resulting in a significantweight gain over
the time and leading to the use of overweight animals as reference
(143). In FR protocols, body weight changes are age and gender
dependent. Breeding weaned mice onto 30% FR lead to gain
weight, even less rapidly than control ones (144). On the contrary,
feeding adult mice (10weeks of age) with 30% FR induces a loss of
20% of their body weight in 1week (145). Thus, such FR models
should be considered as valuable models of balanced feeding as
shown by the induced longer lifespan (146).
In the quantitative food restriction models, the severity of the
restriction generates various levels of weight loss associated with
modifications of energy expenditure and respiratory quotient
(145, 147–150). Indeed, long-term 30% FR in mice leads to a sig-
nificant shift to carbohydrate metabolism during the meal (145).
In rats, a 30% FR applied during 48 h or 14 days induced a signif-
icant body weight loss associated with decrease in plasma leptin
concentrations, but only acute food deprivation leads to a decrease
in glycemia and plasma insulin concentrations. At central level,
both protocols induce up-regulation of hypothalamic AgRP and
NPY mRNA associated with down-regulation of POMC mRNA
(151). A 30% FR applied for 9weeks in 3–week-old mice impacts
bone mineral content more rapidly than when it is applied in
older mice (9–14weeks old) (144, 152, 153). Food restriction is
associated with emotional impairments (154). C57Bl/6 mice sub-
jected to a 20% caloric restriction for 8–12 days exhibit an anxiety-
like behavior (155). Moreover, in 20–30% FR rats for 7–10 days,
a decrease in dopamine levels in the nucleus accumbens occurs
associated with an impairment of the expression of genes related
to the dopamine (156). These alterations could be involved in
reward sensitivity and emotional andmotivation related behaviors
observed in AN patients.
Alternate feeding experiments
Alternate feeding experimentswith animal fed 1 day every two days
appeared to induce alterations close to that observed on 40% FR
models. Mice under alternate feeding from 12 to 65weeks of age
displayed a 20% increase in their body weight while this increase
reached 60% for control mice (157).
Severe food restriction
Severe food restriction studies (50–70% restriction) are much
less common (158, 159). Because of their severity, these studies
are often shorter while numerous changes need several weeks
to develop (160, 161). However, in a 50% FR on a long term
protocol, mice show a decrease in energy expenditure after a
meal associated with a decrease in lipid oxidation (150). Severe
FR on 5-week protocol induced emotional impairments on rats.
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They showed increased anxiety like behavior, decreased serotonin
turnover in the hippocampus and hypothalamus, and a decreased
expression of 5-HT reuptake transporter in the raphe nucleus
(162). Alterations of dopamine and DOPAC levels in septum and
hypothalamus are associated with conditioning fear and control
in food intake (163–167). The dopaminergic signaling was also
shown to be modified (168) in the mesolimbic circuitry, strongly
involved in themodulation of themotivational aspects of the food
intake. Altogether, these protocols mimic various AN symptoms
such as body weight loss associated with alterations in repro-
ductive function, metabolic, endocrine, and neuro-endocrine sys-
tems (Table 3). Moreover, these models bring very interesting
informations about the potential mechanisms sustaining physi-
ological alterations observed in AN, and due to chronic caloric
restriction, but they do not take into account two other major
components widely described in AN, namely stress and physical
activity. Other models have been developed to determine the role
and involvement of both of these factors.
Time-restricted feeding (TR)
Time-restricted feeding consists in ad libitum energy intake, but
within few hours each day. Recently, Rothschild et al. (179) wrote
a comprehensive review on the links between TR and metabolic
diseases in animal models and human. Sherman et al. (219)
showed that a 3-h food access each day for 16weeks induces a
food intake 15% lower and a body weight increase a half lower in
adult male mice compared to their ad libitum control mice. But
in these experiments, restricted animal are fed during the light
period. Longer durations of daily food access were also studied,
but they had a lower impact on food intake and body weight.
Most of the time-restricted studies demonstrated slight or no
changes in body weight gain when compared to control group,
but an improvement of markers of metabolic disease risks. They
also pointed out the link between disruption of the molecular
circadian clock and metabolic disorders even under high fat diet
(219, 220). These models mimic neither severe food restriction
nor body weight decrease described in AN. TR feeding also leads
to a reduction in the anxiety-like behavior and alteration of the
serotonin system of rats (176, 221). The authors suggest that the
decrease in the essential amino acid tryptophan in the hypotha-
lamus may be the consequence of plasma tryptophan decreases,
and thus contribute to the decrease in the serotonin synthesis.
The related hypothalamic variations are suggested to provoke a
compensatory upregulation of postsynaptic 5-HT receptors to
precipitate AN.
Low fat diet
Animal models based on low fat diet (4–5% of fat/g) could take
into account the fact that patients with AN not only reduce their
food intake, but also select their foods. But two main difficulties
limit the use of these models to study AN. First, foods with 4%
of fat are commonly used as low fat diet, even if this is the fat
level suggested for standard rodent food, while 10% fat diets
usually lead to overweight with time and age. Second, almost
all studies focused on comparisons between high-fat and low-
fat diet consequences or focused on the effects of low-fat diet on
obese mice.
Fat-free diet
The first studies conducted on rats submitted to fat-free diet dur-
ing from60 days to 6weeks display a decrease of bodyweight (80%
compared to control), a lower growth with emaciation appearance
associated with increase of water intake, no difference in food
intake compared to control rats (180, 181). It was also described
impairment of reproductive function inmale and female rats (181,
222). Respiratory quotient measured in rats under fat-free diets
(1month) but submitted to carbohydrate access following 14 h of
fasting evidenced a shift to lipid metabolism (182). Variations of
plasma lipid induced by low-fat diet and fat-free diet are sensed by
neurons of ventromedial hypothalamus (223–225). However, to
our knowledge, only the study of Staszkiewicz et al. (185) showed
an upregulation of AgRP and NPY expression in low-fat diet
group. In parallel, a lower dopamine signaling is described in rats
submitted during two generations of α-linolenic acid deficient
diet compared to normal chow diet as well as a lower 5-HT2 bind-
ing was observed till in the frontal cortex, even if no significant
difference was observed concerning body weight between groups
(183, 184, 226, 227). Moreover, although these neurotransmitters
are known to be related to anxiety- and depression-like behaviors,
no behavioral test was conducted in these studies.
Low carbohydrate diet
Patients withAN also select foodwith low carbohydrate content in
the aim to reduce their calorie intake. But in rats, low carbohydrate
diets moderately impact body weight (171), and mice on a zero-
carbohydrate diet significantly gain more weight than animals
consuming standard chow, despite similar caloric intake. These
zero-carbohydrate fed mice also exhibited metabolic disruptions,
while low carbohydrate diets in humans induce greater weight loss
than isocaloric food (228). These results do not lead to consider
low carbohydrate diet fed mice as relevant models for AN. Finally,
studies on high/low fat or high/low carbohydrate diets revealed
great differences in the use of fat and carbohydrate between mice
and humans.
Indispensable amino acid deficient diet (IAA)
Indispensable or essential amino acids are neither synthesized
nor stored in organisms. In AN patients, one might consider that
severe food restriction may alter the concentrations of plasma
essential amino acids and might have drastic nutritional con-
sequences (229). Several studies examining plasma amino acid
levels display conflicting results in AN with higher, lower, or no
significant differences compared to controls (11–13). However,
a decrease in plasma tryptophan and a decrease in the trypto-
phan/large neutral amino acid ratio in acutely underweight AN
patients are usually observed (32, 230–233). Thus, animal models
based on essential amino acid restriction do not appear to be
suitablemodels for AN.However, they couldmimic some induced
alterations, because essential amino acid restriction induces an
adaptive behavior of food deprivation or because they are related
to tryptophan. Various protocols have been developed usingmore
commonly threonine, leucine, or valine deficient diets (189).
Interpretation of changes observed should be taken with caution,
since some alterations are related to energy deficit and others are
related to the amino acid deficiency itself. In particular, valine
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TABLE 3 | Environmental models: main physiological and neurobiological changes observed in rodent models manipulated for one or several factors.
Inducing
factors
Duration Body weight
and tissues
GH/IGF-1 Reproduction Energy metabolism
and appetite
regulating hormones
Stress Central impact
(neuropeptides/
neurotransmitters)
Key
references
Restrictive
anorexia
nervosa
Not well known Months
to years
20–25% under
normal weight
(æfat mass);
osteoporosis
GH resistance
(äGH æIGF-1);
äàSRIF in
CSF; äæSRIF
in blood
Amenorrhea;
æLH,
FSH, E2
æ Energy expenditure;
æLeptin; æInsulin;
äGhrelin (acyl- and
desacyl-ghrelin);
ä adiponectin; æGlycemia
Anxiety-related
behaviors and
mood disorders;
äCortisol; æACTH;
àCRH
Morphological alteration of white
and gray matter; äAgRPäNPY;
àαMSH in blood; æDopamine
metabolites in CSF, æD2/D3
density; æSerotonin markers
(30, 31, 169,
170) (review),
(14, 18, 38)
(review), (32)
Animal models
Mild food
restriction
30–40% food
restriction
Months
to a year
0–20% of
weight loss
(æàlean mass,
æfat and bone
masses)
æ GH;
æIGF-1;
àGHRH
à GnRH æEnergy expenditure;
æLeptin, insulin;
æàGhrelin total,
æDesacyl-ghrelin;
àAdiponectin;
æàGlycemia
Anxiety-like
behavior;àACTH;
äCorticosterone
äAgRPäNPY; æPOMC;
æDopamine and DOPAC in
septum; äDOPAC/dopamine
ratio in hypothalamus
(145, 151,
152, 155,
164,
171–173)
Severe food
restriction
50–70% food
restriction
24 h to
60days
Until 20% of
weight loss
(ælean, fat
masses,æbone
mass)
æGH;
æIGF-1;
äFGF-21
Stop estrus
cycle; æLH,
æFSH
æLeptin, insulin;
äGhrelin (acyl- and
desacyl-ghrelin);
æGlycemia (15 days);
äFree fatty acids;
æKetone bodies;
àTriglycerides; æEnergy
expenditure
äCorticosterone äAgRPäNPY; æPOMC;
æDopamine and DOPAC in
septum; æDOPAC/dopamine
ratio in hypothalamus
(150, 156,
164, 171,
174, 175)
Time-restricted
feeding
6–1 h food
access/day
Until
16weeks
Lower body
weight gain than
control to 25%
of weigh loss
? ? æInsulin; æGlycemia;
æTriglycerides
äàCorticosterone;
àCRH;àACTH
æAnxiety-like behavior;
æSerotonin in hypothalamus;
Circadian clock disturbances
(176–179)
(review)
Low fat and
fat-free
Reduced fat
intake
Two gen-
erations
20% of weight
loss
? Disruption of
reproductive
function
æàEnergy expenditure ? äAgRPäNPY;
äDopamine signaling;
æD2 binding, 5HT2A
binding in frontal cortex
(180–185)
Low
carbohydrate
Reduced
carbohydrate
intake
4weeks No modification
or increase
according food
composition
äGH;
æGH receptor
in liver;
æIGF-1;
æSRIF
? æInsulin fasted;
àGhrelin total,
Acyl-ghrelin; æGlycemia
fasted
? ? (171, 186)
Low essential
amino
acids/protein
Reduced
essential amino
acid protein
intake
2 days to
6weeks
Until 30% under
control weight
æIGF-1;
äSRIF
Stop estrus
cycle
æInsulin; äGhrelin
(acyl- and desacyl-ghrelin);
æGlycemia; æTriglycerides
? No anxiety and depression-like
behaviors; æSerotonin turnover
in brainstem, hippocampus,
prefrontal cortex; involvement of
anterior piriform cortex in
aversion observed
(187–190)
(review)
(Continued)
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TABLE 3 | Continued
Inducing
factors
Duration Body weight
and tissues
GH/IGF-1 Reproduction Energy metabolism
and appetite
regulating hormones
Stress Central impact
(neuropeptides/
neurotransmitters)
Key
references
Dehydration-
induced
anorexia
Hyperosmolar
drink (2.5%
NaCl)
4 days to
2weeks
Until 69% of the
body weight of
controls
? ? æLeptin, insulin;
æTSH, T3
äCorticosterone;
æCRH, CRH-R2
äNPY; æPOMC;
äORX; äTRH
(191–193)
Restraint stress
and
immobilization
Slight
contention
30min to
6 h/day
1–42days 15% of weight
loss (ælean, fat
masses, æbone
mass)
æàGH æ
LH;
æTestosterone
äEnergy expenditure äCorticosterone;
äàCRH;
äàCRH-R1
äNPY, äAgRP; äPOMC;
äMCH, äORX
(194–199)
Cold exposure Exposure to 4 to
 15°C
24 h to
4weeks
Low body
weight loss
(ælean, fat
masses)
? ? æLeptin insulin;
äGlycemia;
äFree fatty acids
äCorticosterone äMCH; äTRH (105,
200–202)
Chronic mild
stress
Random stress 5 days to
8weeks
No or low body
weight loss
(æ fat mass)
? ? æLeptin, insulin äCRH æNPY (203–205)
Social stress Group of rodent
with an
organization into
a hierarchy
2weeks
and
recovery
phase
10–15% of body
weight loss
(æfat mass)
? ? æLeptin, insulin äCorticosterone;
äACTH; äCRH
äNPY; æPreproenkephalin
in nucleus accumbens; äD2
binding in striatum
(206–208)
(review),
(209)
Activity-based
anorexia (ABA)
Voluntary
physical activity
and
time-restricted
feeding
3–14days Stopped over
20–25% of
weight loss
(ælean and fat
masses)
? Stop estrus
cycle
æLeptin, æinsulin;
äGhrelin (acyl- and
desacyl-ghrelin);
æGlycemia; æFree fatty
acids
äCorticosterone;
äAdrenal gland
mass;àCRH
äAgRP, äNPY; æPOMC;
æCART; äDopamine during
feeding in accumbens nuclei;
æSerotonin in accumbens nuclei
(49,
210–215)
(review),
(216)
(review)
Food restriction
and wheel
(FRW)
Voluntary activity
and food
restriction
15–55days 18–22% of
weight loss
(ælean, fat, and
bone masses)
? Stop estrus
cycle
æLeptin; äGhrelin
(acyl- and desacyl-ghrelin);
æGlycemia (15 days);
äFree fatty acids;
æKetone bodies;
àTriglycerides;
æEnergy expenditure
äCorticosterone
(15 days)=
Corticosterone
(55 days)
? (150)
Separation-
based anorexia
(SBA)
Stress related to
separation and
time-restricted
feeding
Until
10weeks
and
recovery
phase
Until 28% of
weight loss
(ælean and fat,
æbone masses)
äGH;
æIGF-1
Stop estrus
cycle
æLeptin;àGlycemia æACTH;
äGlucocorticoïd
äMHPG/norepinephrine
in hippocampus; æDopamine in
hippocampus
(161, 217,
218)
ä increase; ædecrease;àno changes of expression or concentration according to the compartment studied; ? not well-documented.
5HT2A, serotonin receptor 2A; ACTH, adrenocorticotropic hormone; AgRP, agouti related peptide; CART, cocaine and amphetamine regulated transcript; CRH, corticotropin-releasing hormone; CRH-R, corticotropin-releasing hormone-
receptor; D2 receptor, dopamine receptor 2; DOPAC, 3,4-dihydroxyphenylacetic acid; E2, estradiol; FSH, follicle stimulating hormone; GH, growth hormone; GHRH, growth hormone-releasing hormone; IGF-1, insulin-like growth factor 1;
LH, luteinizing hormone; MCH, melanin-concentrating hormone; NPY, neuropeptide Y; ORX, orexin; POMC, pro-opiomelanocortin; SRIF, somatostatin; TRH, thyrotropin-releasing hormone; αMSH, alpha-melanocyte-stimulating hormone.
The gray parts of the table point animal models induced by several factors.
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deficient diet induced food restriction, a greater weight loss than
for other IAA diets (approximatively 20% of their initial body
weight), and increased of plasma acylghrelin and des-acylghrelin
concentrations after 6 days of protocol (188). However, this valine
deficient diet must be taken with caution since it leads to neuro-
toxicity not observed with an isoleucine deficient diet for example
(189, 234–236). In another series of experiments using a com-
bination of IAA deficient diets, Narita et al. (189) showed after
15 days of protocol, a decrease of glycemia, plasma triglycerides,
leptin, insulin, and IGF-1 levels as well as a blockage of the estrous
cycle in diestrus stage. Chronic tryptophan deficient diets (until
6 weeks) in rodents also lead to a progressive decrease of body
weight (237–239). In contrast to acute deficient diet, no anxiety- or
depressive-like behavior was observed in rodent despite a decrease
in tryptophan concentration and serotonin turnover in brain-
stem, hippocampus, and prefrontal cortex (238–241). Indeed, no
sucrose preference was observed in acute deficient rats while
an increase of sucrose consumption was observed in mice after
5weeks of tryptophan deficiency (239, 241). Unfortunately, to our
knowledge, no studies determine the alterations of brain circuits
regulating energy homeostasis. Rodents also develop different
strategies to overcome the amino acid unbalance, including stop-
ping the ingestion of food, change in the choice of food; they also
develop a foraging behavior (to find complementary food); they
establish an aversion with a learning phase and memorization of
taste and smell to avoid the consumption of deficiency food in
future (190, 242–244).
Dehydration-induced anorexia
As highlighted in part I, AN patients present relatively frequent
osmoregulation impairment and renal complications due to their
drink intake behaviors (21, 245, 246). Gutman and Krausz (247)
pointed out a drastic decrease of food intake after acute subcuta-
neous injection of a hypertonic solution in rat. A “dehydration-
induced anorexia” (DIA) model was developed by Watts (248). It
consisted in a scheduled consumption of a hyperosmolar solution
of NaCl (2.5%). This protocol has been tested for 4–14 days (192,
248). It provokes reduced food intake with a negative energy
balance that is similar to those seen in pair-fed food-restricted ani-
mals: weight up to 69% under the body weight of control rodents,
increased corticosterone, lowered leptin and insulin plasma levels
(191). The food restriction is due a change in the pattern of food
intake, a reduction of meal duration, and an inhibitory effect on
gastric motility (249, 250). At the central level, DIA and pair-
fed groups share up-regulation of NPY and down-regulation of
POMCmRNA in the arcuate nucleus, and up-regulation of orexin
mRNA in the lateral hypothalamic area only in pair-fed groups
(191, 193). Beside, a down-regulation of CRH mRNA expression
in the paraventricular nucleus and higher plasma corticosterone
levels are observed only in DIA group (192). This model displays
some common alterations also observed in AN. However, the
drastic changes in osmolarity, which are not always observed in
patients, might limit the use of DIA to decipher the central and
peripheral mechanisms that can lead to chronic renal failure.
Stress models
A growing body of literature associated stress and anxiety as
critical factors in the development of eating disorders like AN
(251). Several animal models have been developed to evaluate
mechanisms linking response to stressful events and alterations
of food intake. In this section, we will not discuss data related to
anorexia induced by the administration of lipopolysaccharides or
endotoxemia. The most extensive studies concern restraint stress,
cold exposure, or chronic mild stress (CMS).
Restraint stress
In rodents, limiting movements for a determined period (30min
to 6 h) every day generates a stress and a body weight decrease
depending on the duration and type of immobilization (195).
Indeed, animals are immobilized in a plastic tube or by attaching
the four limbs to metal mounts with adhesive tape. Body weight
loss up to 15% impacts both lean and fat masses, and is associated
with a voluntary food restriction after an acute stress session (like
2 h), or when the stress is repeated (195, 252–254). Moreover, this
low body weight is maintained even after a recovery period (199).
Repetition of the restraint stress induces long lasting increased
plasma corticosterone, ACTH and ghrelin concentrations, and
decreased plasma leptin and insulin concentrations (255–258). In
long duration experiments, bone physiology alterations are also
observed (259). Rats exhibit an increase of energy expenditure
and body temperature during the stress followed by return to
control values (199, 260). At central level, noticable changes in
the activation and/or expression of genes involved in the control
of food intake are described. Acute restraint stress increases the
number of activated neurons in several brain areas compared
to controls, while repeated stress effects are lowered probably
because of habituation (261–263). In these studies, modifications
in the activation of the HPA axis are the most documented.
Restraint stress protocols increase plasma corticosterone concen-
trations, which are associated with an increased activation and
expression of CRH in the paraventricular nucleus (198, 264).
However, such increases are not anymore observed when the
stress is repeated (198, 199, 265). Considering the anorexigenic
effects of intracerebroventricular injections of CRH, this peptide
has been suspected to be responsible for the voluntary food
restriction observed in this type of protocol (265). Both acute
and repeated restraint stress in rats induce decreased number of
neurons immunoreactive for Fos and AgRP in arcuate nucleus,
while the number of neurons immunoreactive for Fos and MC4R
increases in the lateral hypothalamic area but decreases in the
arcuate nucleus on the long term (263). Such reduction in MC4R
cell activation may signify a desensitization of feeding regulatory
pathways in the arcuate nucleus after repeated stress exposure that
may be indicative of a shift toward more orexigenic behaviors, as
signals promoting feeding become more prominent. In another
study where a 2-week chronic restraint stress is applied on mice,
inhibition of food intake occurs until the end of the first week
and is associated with also an up-regulation of POMC mRNA in
the arcuate nucleus (258). The data obtained with NPY are less
clear since acute restraint stress increases NPY mRNA expression
in the arcuate nucleus. This expression is normal in the case of
chronic stress (266). Thus, the relative balance between orexigenic
and anorexigenic pathway activation appears to be dependent on
whether the stress is acute or repeated. Finally, stress induces
a very rapid degradation of GH (267) and thus a decrease in
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plasmaGHconcentrations (268, 269). The release of somatostatin,
a major inhibitor of the GHRH release, increases in the median
eminence level following acute restraint stress, and thus might be
a major factor in this GH drop (270).
These results suggest that food intake may be increased or
decreased as a consequence of stress, and may play a role in
eating disorders from anorexia to binge-eating leading to obesity
and other stress-associated metabolic disorders. Once again, this
psychological stress impacts differentially the brain areas involved
in the regulation of food intake rendering difficult to use such
protocol to study precisely the mechanisms involved in AN.
Cold exposure
One hypothesis on the origins of hyperactivity often observed
in AN is that it would be a form of thermoregulatory behavior.
Studies on the effects of ambient temperature or heat treatment on
AN patients displaying hyperactivity strengthen this hypothesis
(271, 272). Cold exposure is a physiological stress used to deter-
mine mechanisms involved in control of body temperature. The
protocol used temperature exposure from 4°C to -15°C and for
a duration ranging from 24 h to 4weeks. Usually, relatively low
body weight loss is observed and is not always associated with
a decrease in food intake (200–202, 273–276). This body weight
loss is associated with a decrease in both lean and fat masses and
an increase in brown adipose tissue mass (202, 277–279). Short
term exposure (1–24 h) or long term exposure (8 days) to cold
stress (at 4°C) increases blood glucose, plasma adrenaline, and
corticosterone concentrations, and decreases plasma leptin and
insulin concentrations (200, 276, 279, 280). Cold exposure also
leads to increased glucose uptake by peripheral tissues associated
with increased liver glycogen, lipolysis inwhite and brown adipose
tissues, and concomitant to lipogenesis in these tissues (200, 279,
281). Activation of lipolysis in the different fat depots involves
the sympathetic nervous system as suggested by an increased
noradrenergic turnover (276, 277). Lower temperatures (under
0°C) during 2weeks induced in mice, a more important body
weight loss associated with higher food intake and lower body
temperature (202). Cold exposure leads to activation of numerous
brain areas involved in thermoregulation located in the hindbrain
(282, 283), in the hypothalamus, and in the forebrain (280, 284).
Cold exposure during 4 days (4°C) leads also to increase of MCH
expression in the hypothalamus (201), suggesting the involvment
of this neuropeptide directly or indirectly in such variations.
However, the origin of these variations is unclear but they are
probably due to the role of MCH in control of energy expenditure
(201, 285).
Chronic mild stress
Depression is another sign classically observed in AN. The most
valuable animal model of depression like behavior was developed
by Willner et al. (203). This model called CMS consists to expose
rodents to mild stress applied randomly and daily during 3 to
9weeks. In this kind of protocol conducted on rodents, the body
weight is slightly diminished but, a notable reduction of sucrose
consumption, sign of anhedonia, is described (203, 204, 286, 287).
The body weight loss concerns decreased subcutaneaous and vis-
ceral fat mass associated with decreased plasma leptin and insulin
concentrations. However, these changes are not specific to CMS
protocol because they are also observed in the “weight match”
control group (205). At central level, CMS animals exhibit up-
regulation of CRH in paraventricular nucleus while its expression
is reduced in the “weight match” group (205). Other peptide
expressions also are altered, with especially a down-regulation
of NPY in the arcuate nucleus (204). The CMS is described to
have anxiogenic effects through a stronger neuronal activation
in various brain areas, as well as a decreased neurogenesis in the
hippocampus (288). Recent reviews (289–291) pointed out a role
of ghrelin in depression and anxiety, even if it is again still a subject
of debate. Its receptor is present in structures known to be involved
in mood disorders like hippocampus and amygdala. The model
presents the advantages to mimic alterations of the stress axis and
anhedonia for palatable food associated with a slight body weight
loss. However, the complexity of the stress procedure and a rapid
recovery limit the interest of CMS to mirror AN.
Social stress
Another kind of acute/chronic stress is related to rodent social
interactions. The main models are based on social defeat stress
and the visible burrow system (VBS). The social defeat stress
was first used as a model of anxiety and depression (292). A
rodent (intruder) is placed in the home cage of another rodent
(resident). The interactions between the two animals are usually
rapid and lead to aggressive behaviors, with a dominant and a
subordinate. The defeat social stress leads to a markedly decrease
of body weight in animal following 1 h session of stress (206).
The repetition of this stress induces also a higher reactivity to
an acute restraint stress with increased plasma corticosterone and
ACTH concentrations, but with a normalization of values after
stress (293). A decrease in locomotor activity is also observed
associatedwith reduced social interaction in the presence of a non-
aggressive rodent (206, 293). An increased nocturnal food intake
is noticed and not observed in the case of VBS protocol (209, 293).
The VBS protocol induces a more complex social defeat stress
since it is based on the establishment of a hierarchy in a group
of male rats leading to dominance hierarchies with offensive and
defensive behaviors (294). At the end of the confrontation period,
a dominant male rat (DOM) takes the ascendancy over other
rats qualified like subordinate males (SUB). VBS protocol induces
decrease of body weight associated with a decrease of food intake
only in SUB male rats (208, 209, 295). The body weight reduc-
tion is associated only with a decrease in subcutaneous fat mass,
whereas lean mass is unchanged and visceral fat mass is increased
(208). The pattern of food intake is modified with a decrease of
meal duration (209). SUB rats display also endocrine changes with
a decrease of plasma leptin and insulin concentrations compared
to DOM and control rats (296, 297). Studies related to alterations
at the central level have mainly focused on the HPA axis, particu-
larly affected in the SUB rats, with increased plasma corticosterone
concentrations correlatedwith increased expression of CRH in the
paraventricular nucleus and amygdala (208, 295, 296, 298). The
chronically elevated corticosterone levelsmay create an orexigenic
drive through upregulation of NPY and AgRP in the SUB rats
as well as the loss of fat mass seen in both DOM and SUB,
which indicates a negative energy balance, and may also create an
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orexigenic drive through similar mechanisms. Such observations
are validated by the behavior observed in a recovery phase where
the rodents become hyperphagic and increase drastically their
fat mass (299). These observations render the model inadequate
for studying the recovery period after food restriction even if the
model generates transiently a food restriction during the protocol.
It should be underlined that a noticable decrease of palatable food
is observed as in the CMS protocol in the recovery phase (207,
208, 300). These changes have been attributed to alterations in
dopamine transporter binding and dopamine receptor (D2) bind-
ing which are reduced or increased respectively in the striatum
and accumbens nucleus in SUB group (207). The VBS protocol
also leads to changes in the SUB serotonergic system in various
brain areas involved in the modulation of stress (294, 301). This
model is interesting to study the impact of chronic social stress on
food intake and its homeostatic and non-homeostatic regulation.
But the main drawbacks are: the absence in human of such notion
of subordinate and dominant; the recovery period which shows
a binge-eating behavior that is rare in recovered AN patients; the
short term duration (around 15 days) excluding the development
of long term alteration like osteoporosis. Finally, there is currently
no or few data about the regulation of energy balance. The VBS
model presents an important limit that reduces its use to study
AN: it is applicable only on males.
Animal Model Based on Several Inducing Factors
Separation-based anorexia
Separation-based anorexia model is another model of chronic
social stress not often used until now. Thismodel is based on stress
produced by a physical separation of mice belonging to the same
group and associated with a food restriction or a time-restricted
feeding (TR) (217). This study was initially conducted on Sabra
female mice. Only few studies were published on this strain of
mouse with high body weight. Food was provided during the light
phase for 1 h a day. Control mice with the same feeding schedule
lost 10% of their day 0 body weight within 18 days, and daily
ate 2.84 g of food. Separated and time-restricted mice lost 28%
of their initial body weight, and daily ate 2.33 g of food. In this
group, 21% of mice died before reaching the targeted body weight
loss of 33–35%. Separated and time-restricted mice ate 65% of
the daily requirements and reach the same level of body weight
loss than mice fed 40% of the daily requirements without being
separated. These data suggested that separation of mice increases
metabolic demands. This first study was followed by two studies
on the samemodel and conducted by the same team. Both of them
dealt with the effects of tyrosine treatments on central nervous
system functions. Hao et al. (218) showed that SBA mice display
an increase in 3-methoxy-4-hydroxyphenyglycol/norepinephrine
ratio, an up-regulation of the cholinergic signaling, and a decrease
in the dopamine concentration in hippocampus. In 2002, the
effects of tyrosine treatments on HPA axis were studied on this
model (302). This second central study pointed out a specific
pattern of central alterations in SBA mice when compared to FR
and active mice despite similar body weight loss. To allow studies
on long term metabolic and central adaptations on a usual mouse
strain, we recently adapted this model to C57Bl/6 young adult
female mice. Food access was progressively reduced from 6 to
2 h a day within 2weeks and then maintained at 2 h a day for
up to 8weeks (161). We have shown that this protocol induces
significant weight loss with a reduction from 20 to 25% of initial
body weight. Interestingly, the body weight loss observed in SBA
group is not attributable to the timed food access as SBA mice eat
only 10% less than ad libitum group. Moreover, such a difference
in body weight is not observed in the TR group without separa-
tion. We suspect that this difference is partly due to rising energy
costs both through the separation-induced stress and higher ther-
mogenesis needs caused by the separation. Body weight loss is
related to a decrease in lean mass and visceral and subcutaneous
fat masses. In parallel, SBA mice present a blocking of their
reproductive function and bone mass gain. Like in AN patients,
various endocrine changes are observed. Thus, SBA mice display
lower plasma leptin concentrations. Furthermore, disruption of
the GH/IGF-1 associated with alteration in bone physiology was
observed at 2 and 10weeks. Atmetabolic level, protocol induces an
up-regulation of several genes (UCP1, PGC1a, Prdm16) especially
in the subcutaneous adipose tissue of SBA mice, suggesting the
emergence of beige/brite adipocytes in this specific fat depot.
Moreover, after 10weeks of SBA, protocol mice were submitted to
a 10-week recovery period with free food access in normal cage.
During this recovery period, mice correct their various alterations
including body weight, food intake, reproductive function, body
composition, endocrine factors, and adipose tissue metabolism.
However, SBA mice maintain low plasma leptin concentrations
and low leptin expression in visceral fat tissue despite a full
normalization of fat mass (161).
This long term model appears interesting as it mimics numer-
ous central and peripheral alterations described or suggested in
AN, and allows a recovery study. However, the increased energy
expenditure related to chronic stress and high needs of thermoge-
nesis does not match the decrease usually described in patients.
Activity models
In 1967, Routtenberg and Kuznesof developed a protocol, where
rats isolated in a cage were allowed to have a timed food access, 1 h
per day, combined to a voluntary activity. This model later named
activity-based anorexia (ABA)/self-starvation/semistarvation-
induced hyperactivity/food restriction-induced hyperactivity/
wheel-induced feeding suppression model produces a rapid
weight loss, close to 25% of their initial weight within days
and food intake, physical hyperactivity, hypothermia, impaired
estrous cycle in females, and increases in HPA axis activity (215,
303, 304). Moreover, rats eat less than inactive rats fed with the
same schedule. This procedure led rapidly to a “self-starvation”
or self-deprivation behavior resembling to that observed in
restrictive AN patients and leading rapidly to the death of
animals due to the voluntary privation of food (around 7 days).
It is currently the most well-known animal model of anorexia
(216, 305) and has been adapted to mice (306, 307). Recently,
Lewis and Brett (308) reduced progressively the food access
duration to maintain mice longer than 7 days. Following this new
protocol, Jésus et al. (309) demonstrated alterations of intestinal
permeability. In many aspects, all these models mimic numerous
physiological alterations observed in AN. However, as specified
in the review of Klenotich and Dulawa (310), the ABA paradigm
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is strongly dependent on the rodent strain, on age and gender
(307, 311), on temperature [increasing the temperature to 32°C
strongly reduces the ABA behavior, (312)], and on the time of
the day the animals receive food. In fact, Boakes and Juraskova
(313) and Boakes (210) demonstrated that the “self-starvation”
observed in ABA rats might reflect both the reduced palatability
of the dry chow for a dehydrated animal and satiety signals from
a stomach full of water. Finally, in all these protocols, rodents
were isolated in their cage to permit individual metabolic and
physiological measures, but isolation creates a social stress adding
on the physiological stress of food deprivation, rendering the
protocol more drastic. Thus, all these studies present limitations
that maintain a distance with AN. Recently, we have developed
a modified ABA model on female mice, named here Food
Restriction and Wheel (FRW) model that aims: (i) to prevent the
social stress by using two mice per cage and (ii) to follow on the
long term (up to 10weeks) physiological alterations induced by
a combination of physical activity and a food restriction of 50%
(150). All of these activity models present metabolic, endocrine,
and neurobiological alterations that might be the basis to study
adequately some of physiological mechanisms altered in AN
patients. Finally, they all exhibited a FAA, which occurs between
2 and 5 h before food intake distribution, and which is also
described in AN patients (314).
The body weight loss observed both in ABA and FRW rodents
is related to decrease of lean and subcutaneous/visceral fat masses
after 7–14 days of protocol (150, 315). Physical activity at short
term exacerbates decreased fat mass and has no protective effect
on bone composition and lean mass (150, 211, 213, 316). When
the protocol is maintained on the long term (55 days) like in FRW
protocol, physical activity participates to bodyweight stabilization
and to a significant slight body weight regain compared to pair-
fed group (150). The long term protocol induces alterations in
the bone mineral content leading in AN patients to osteoporosis.
Indeed, in FRW mice, physical activity, currently described to
stimulate bone formation, did not prevent on long term proto-
col the termination of bone mass acquisition induced by food
restriction. Similar data were also described in SBA female mice
subjected to a protocol of chronic stress associated with caloric
restriction as previously mentioned. Such data confirmed the
absence of protective effect of activity on bone mineral content in
AN. In the ABA model, Pardo et al. (315) underline a differential
tissue-specific expression pattern of ghrelin and leptin receptor at
peripheral level reflecting tissue specific mechanisms to control
energy homeostasis. The study of intestinal barrier indicates that
the ABA protocol generates an increased colonic permeability
associated with altered tight junction expression (309). These
recent data open new windows to decipher the impact of gut
microbiota in the deregulation of energy metabolism as well as
the hepatic injury occurring in AN patients.
Besides alterations in various peripheral tissues, numerous
endocrine changes are similar to that described in AN patients.
Overall, ABA mice present lower plasma leptin and insulin con-
centrations and higher total plasma ghrelin and corticosterone
concentrations (212, 215, 317). Moreover, energy metabolic fac-
tors are also changed in ABA/FRW mice with, in particular,
an increase of free fatty acid and a decrease of glycemia (150,
213). On the long term, most of the endocrine alterations per-
sist like lower plasma leptin concentrations, higher plasma total
ghrelin concentrations still associated to lower glycemia, plasma
ketone bodies, and higher free fatty acid in FRW mice (150). As
highlighted previously, food restriction might induce shift in the
energy metabolism regulations. Combination of food restriction
and voluntary physical activity leads to a higher carbohydrate
metabolism and a lower fat oxidation during the light period
like the ad libitum control groups whereas at long term, FRW
mice adopt a similar profile than the pair-fed group with a lipid
metabolism more prominent. These changes point out the com-
plexity of the peripheral regulation of nutrient and energy sup-
plies, engaging probably hormones like leptin or ghrelin, which
act on adipose tissues, muscles, or liver, might contribute to the
changes/reduction in energy expenditure observed in FRW and
pair-fed controls both at short and long term.
Central alterations are also observed in ABA protocols with
an up-regulation of AgRP and NPY mRNA expression associ-
ated with a down-regulation of POMC and CART expression in
the arcuate nucleus compared to control mice (211, 318–320).
Surprisingly, no differences were observed concerning MCH and
orexin expression in lateral hypothalamic area or CRH expression
in paraventricular nucleus (211). However, until now, there is no
study that evaluates potential changes in the expression of ghrelin
and leptin receptors in ABA mice. Such information might be
of importance since GHSR KO mice or intracerebroventricular
injection of GHSR1a antagonist decreased the behavior of FAA
and did not modify the food intake (321). Likewise, chronic
subcutaneous or intracerebroventricular leptin injections lead to
lower running wheel activity associated or not with reduction
of food intake (322–324). Such fundamental researches are con-
ducted to aim finding potential treatment using leptin or ghrelin
to reduce hyperactivity frequently associatedwithAN, and leading
to its excessive to emaciated phenotype. Indeed, intracerebroven-
tricular injection of αMSH, whose release in hypothalamus is
stimulated by leptin, enhances the ABA phenotype (325). Like-
wise, the specific sites of action of ghrelin and/or leptin in the
ABAprotocol should also be clarified. As an example, injections of
ghrelin agonist in the lateral dorsal tegmental nucleus or its target,
the ventral tegmental area, stimulate locomotor activity and food
intake (326, 327). ABA mice are also shown to exhibit higher
concentrations of noradrenaline, serotonine, but lower dopamine
concentrations in the mediobasal hypothalamus compared to
pair-fed and control groups (302, 328, 329). Moreover, Verhagen
et al. (214) showed in the nucleus accumbens of ABA rats a lower
circadian serotonergic activity without any changes for the circa-
dian dopamine activity compared to control. These monoamines
were suggested to play a role in voluntary food restriction in ABA
rodents and in comorbidities observed inANpatients [i.e., depres-
sion or obsessive compulsive disorders; (137)]. It was suggested
that reduction of physical activity is due to inhibition of serotonin
release via 5HT1A autoreceptors in raphe nucleus (329–333). The
opioid and endocannabinoid systems are also modified in the
ABAmodel with increased plasma βendorphin concentration and
pituitary βendorphin content in rats (334). This hyperendorphin-
ism in the hypothalamo-pituitary-adrenal axis was linked to the
auto-addiction hypothesis of AN. Furthermore, intraperitoneal
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injections of ABA mice with ∆9-tetrahydrocannabinol, an exo-
gene ligand of cannabinoid receptors, increase their food intake,
attenuate the body weight loss, reduce the energy expenditure, but
increase the mortality rate compared to ABAmice vehicle-treated
(308, 335). Due to the large distribution of endocannabinoid and
opioid receptors in the brain, further studies are needed to clarify
more precisely the mechanisms involved and the finely tuned
interactions between all these homeostatic and non-homeostatic
structures.
The ABA/FRW protocols also affect two other main endocrine
functions: stress and reproduction. In ABA rodents, like in FRW
mice (on the short and long term), a disruption of estrus cycle,
vaginal closure, and reduction of ovaries size, and also hormone
disturbances including a decrease of plasma testosterone and
luteinizing hormone concentrations have been noted (150, 329,
336, 337). Reproduction axis is normalized when rodents are
placed in recovery conditions, which reflect that reproductive
disturbance is the result of energy unbalance (337). Concerning
the HPA axis, ABA protocols induce on the short-term increased
plasma corticosterone and ACTH concentrations and adrenal
gland hypertrophy, but no significant modification of CRH
expression in paraventricular nucleus compared to controls (211,
318, 338). Intracerebroventricular injection of CRH antagonist
injection during the protocol leads to blunt the ABA phenotype
(318). Furthermore, ABA adrenalectomized rats do not display
increased wheel running activity (212). Once again, these data
suggest that HPA axis is essential to apparition of ABA phenotype
and point out the role of the glucocorticoids in the pathophysi-
ology of AN. Somatotrope axis is another axis disrupted in AN
patients, but in our knowledge there is no study using ABA
protocol or associated protocols showing such alterations.
As mentioned earlier, one characteristic of the ABA model is
the FAA. Several studies have documented the potential factors
and neuronal structures leading to this particular behavior that
can be generated like a foraging behavior or to increase the internal
temperature due to energy deficit (212, 215, 321–323, 339). FAA
itself can also influence the pattern of food intake. Indeed, in
the FRW protocol, mice display a shift in the meal initiation
compared to the pair-fed group (150). One explanation, suggested
by Woods (340), considered eating to be a homeostatic stressful
event, because the digested nutriments that reached the blood
during and after a meal markedly disrupt energy homeostasis.
Thus, the combination of both events, activity and feeding, could
generate a stressful energy event especially in the short term,
leading to increase in corticosterone levels and resulting to delay
the meal initiation. Such phenomenon could occur in the ABA
FIGURE 1 | Schematic representation of the relevance of the different
animal models for anorexia nervosa, environmental and genetics,
described in the review. The more the models mimic restrictive anorexia
nervosa symptoms the closer they are to the center of the figure. In the
environmental models, the squares correspond to models based on one
inducing factors and the circles to models based on several inducing factors. In
the genetic models, the pentagons point out genetic models with spontaneous
mutations whereas the diamonds show the genetically engineered mice: knock
out (KO), transgenic ("), specific deletion (#). ABA, activity based anorexia;
AgRP, agouti related peptide; CB1, cannabinoid receptor type 1; CCK,
cholescystokin; CRH, corticotropin releasing hormone; FR, food restriction; IAA,
indispensable amino acid deficient diet; GOAT, ghrelin O-acyltransferase; Hcrt,
orexin/hypocretin; MCH, melanocortin concentrating hormone; NPY,
neuropeptide Y; PP, polypancreatic peptide; PYY, peptide YY; SBA, separation
based anorexia; TH, tyrosine hydroxylase; TR, time-restricted feeding; 5-HT R,
serotonin receptor.
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model, where the pattern of food intake has never been mea-
sured in metabolic cages, as it was done for FRW mice. The
“self starvation” observed might thus be due to this delay in the
initiation of the meal, which is, as mentioned above, time limited.
Concerning the temperature, theABAprotocol induces a decrease
of body temperature (341, 342). In addition, even if a negative
correlation between FAA and body temperature was observed,
no causal link has been demonstrated (325). Nevertheless, it was
suggested that the decrease of body temperature is one of the
factors contributing to physical activity (342). When ABA rats
have access to a warm platform, they decrease their running wheel
activity (320, 325, 343), similarly as observed in AN patients
whose excessive physical activity vary depending on the ambient
temperature (272).
All the data collected with both ABA and FRW models are
totally useful to dissect the different mechanisms involved in
the maintenance of the AN phenotype. Combining the different
approaches on the short and long term will have an indubitable
benefit to study the interactions between the various peripheral
and central actors whose dialogs seem strongly impaired.
Conclusion
This review aims to depict the different animal models currently
used or potentially interesting to study one or several aspects of
restrictive AN (Figure 1). The definition of a pertinent animal
model of psychiatric disorder remains extremely difficult. In the
case of AN, more specially the restrictive subtype, many symp-
toms can be mimicked in rodents like the body weight loss, the
changes in energy expenditure, increased physical activity, several
endocrine and neurotransmitters changes that reflects similar
physiological and neurobiological mechanisms inherent to the
natural and adapted regulation of feeding. In this sense, some of
the currently available animalmodels described here answer to the
“face validity,” i.e., theymimicmost of the symptoms of the human
pathology. However, AN is usually associated with a refusal to eat.
In rodents, such behavior is not natural, even if a kind of self-
starvation is observed in migratory and hibernating animals. The
“self-starvation” induced by some protocols does not reflect the
human starvation, which is classically described to be associated
with a personality trait involving neuronal inhibitory cognitive
circuits. Even if self starvation is observed in somemodels like the
well known ABAmodel, onemay considered that the starvation is
essentially due to physiological factors like temperature, dryness
of the food, or even the delay in the initiation of the meal due
to the intense physical activity observed before feeding. These
models give certainly important information’s about the physio-
logical changes occurring at this period, but do not reflect the self-
starvation observed in human, which remains to be understood.
Is it only driven by cognitive inputs or is it under the influence
of factors regulating the feeding homeostasis like ghrelin or leptin
which receptors are distributed in numerous “non-homeostatic”
brain areas? Brain imaging might help to solve this question
and would permit to give more credit to what we obtained in
animal models. Even if all of these models do not fully answer to
criterion of “construct validity,” i.e., a common etiology or similar
conditions of induction, they fulfill the “predictive validity,” as
the different pharmacological treatments used to restore body
weight and other altered functions give encouraging results. As a
conclusion, it is to note that current environmental models based
on a combination of several inducing factors appear to be more
relevant than the other models but may be to further improve
studies on AN, new models coupling genetic and environmental
factors remain to create and assess.
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